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Background:  Rotavirus  is the  leading  cause  of  severe,  dehydrating  diarrhea  in  children  aged  <5  years
globally,  with an  estimated  25  million  outpatient  visits  and  2 million  hospitalizations  attributable  to
rotavirus  infections  each  year.  The  aim  of  this  hospital-based  surveillance  was  to  summarize  the  local
epidemiological  and  virological  features  of  rotavirus  and  to estimate  the  disease  burden  in the  population
under  surveillance  in  India.
Methods:  During  the  16  months  surveillance  period  from  April  2011  through  July 2012, a total  of  4711
children  under  the  age  of 5  years  were  admitted  with  acute  diarrhea  at 12  medical  centers  attached  to
medical  schools  throughout  India.  Stool  samples  were  randomly  collected  from  2051  (43.5%) subjects  and
were analyzed  for rotavirus  positivity  using  commercial  enzyme  immunoassay  kit (Premier  Rotaclone
Qualitative  Elisa)  at the  respective  study  centers.  Rotavirus  positive  samples  were  genotyped  for  VP7  and
VP4 by  reverse-transcription  polymerase  chain  reaction  (RT-PCR)  at  a central  laboratory.
Results:  During  the study  period,  maximum  number  of  rotavirus  related  hospitalizations  were  reported
from  December  2011  through  February  2012.  Out  of the  2051  stool  samples  tested  for  rotavirus,  overall
541  (26.4%)  samples  were  positive  for rotavirus  VP6 antigen  in  stool.  The  highest  positivity  was  observed
in  the month  of  December,  2011  (52.5%)  and  lowest  in  the month  of May,  2011  (10.3%).  We  found  that
majority  of  the rotavirus  positive  cases  (69.7%)  were  in  children  <24  months  of  age. The  most  common
genotypes  reported  were  G1 (38%),  G2  (18%),  G9  (18%),  G12  (9%)  and  mixed  strains  (17%).
Conclusions:  The  results  of  this  study  conﬁrm  the signiﬁcant  burden  of  acute  rotavirus  gastroenteritis  as
a cause  of hospitalizations  in under  ﬁve  children  in India.
©  2014  Published  by Elsevier  Ltd.  This  is an  open  access  article  under the  CC  BY-NC-ND  license
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. Introduction
Rotavirus infection, mostly caused by Group A viruses, is preva-
ent in human populations worldwide. Although the virus infects
lder individuals, the disease can be severe in immunologically
aïve infants and young children. The burden of severe rotavirus
llness and deaths falls heavily upon children in low and middle-
ncome countries: more than 80% of rotavirus-related deaths are
stimated to occur in lower income countries of Asia and sub-
aharan Africa [1].
India has an especially large population at risk of clinically signif-
cant rotavirus gastroenteritis (GE); of the 1.2 billion people, 11% are
5 years old. Worldwide in 2008, diarrhea attributable to rotavirus
nfection resulted in 453,000 deaths (95% CI 420,000–494,000)
n children younger than 5 years representing 37% of deaths
ttributable to diarrhea and 5% of all deaths in children younger
han 5 years. Five countries accounted for more than half of all
eaths attributable to rotavirus infection: Democratic Republic of
he Congo, Ethiopia, India, Nigeria, and Pakistan with India alone
ccounting for 22% of deaths (98,621 deaths) [2].
Typical clinical signs of infection include fever, projectile
omiting, and profuse watery diarrhea, which may  signiﬁcantly
ehydrate the infected child. Moderate to severe dehydration in
oung children is more often associated with rotavirus infection
han other enteropathogens. There are no speciﬁc medications for
otavirus GE, but rehydration with oral rehydration salts (ORS) has
ong been a standard therapy for acute infantile diarrhea. Severe
ehydration can be life threatening and requires treatment in a
linic or hospital where the child can receive intravenous (IV) ﬂuids
nd appropriate case management.
The purpose of this observational study was to carry out a
ospital-based surveillance of rotavirus gastroenteritis in children
59 months of age and develop estimates of disease burden in the
opulation under surveillance.
. Methods
.1. Study centers and duration
A prospective hospital-based surveillance was conducted at 12
edical centers attached to Medical Schools across India. From
orth India subjects were enrolled from Dayanand Medical College
 Hospital, Ludhiana; Chhatrapati Shahuji Maharaj Medical Univer-
ity, Lucknow; Kalawati Saran Children Hospital, New Delhi; Post
raduate Institute of Medical Education and Research, Chandigarh
nd Sawai Man  Singh Medical College, Jaipur. From South India,
andhi Medical College, Hyderabad; JSS Medical College, Mysore;
empegowda Institute of Medical Sciences, Bangalore and Kasturba
edical College & Hospital, Manipal were involved. From Western
ndia, Goa Medical College, Goa recruited subjects. From Eastern
art of India subjects were enrolled from Institute of Child Health,
olkata and Kalinga Institute of Medical Sciences, Bhubaneswar
Fig. 1).
The 16 months surveillance study was conducted from April
011 through July 2012.
.2. Inclusion criteria
Children ≤59 months of age presenting with severe acute gas-
roenteritis (deﬁned by the passage of ≥3 looser than normal stools
ith or without vomiting during the preceding 24 h period) andequiring hospitalization for at least 6 h were eligible for this study.
n approved informed consent statement for obtaining stool sam-
les was then read and signed by the parents/legally acceptable
epresentatives of the subject, investigator and, when required, aFig. 1. Study centers across India.
witness. Upon obtaining consent, subjects were included in the
study and their stool sample was obtained. Children older than 60
months, and those younger than 60 months but not requiring hos-
pitalization for at least 6 h or whose parents did not consent for
stool sampling were not included in the study.
2.3. Clinical assessment
Various parameters considered for clinical assessment of diar-
rheal severity were: time of onset, duration and maximum number
of episodes of diarrhea and vomiting, intensity of fever and dehy-
dration. These parameters were recorded in a Case Report Form.
Severity of diarrhea was assessed using the Vesikari scoring system.
As per the Vesikari Score Grading, a grade of 0–5 was considered as
mild, 6–10 as moderate, 11–15 as severe and more than and equal
to 16 as very severe [3].
2.4. Stool specimen collection
Approximately 5 ml  of stool sample was  collected in stool
containers from the consenting subjects either on the day of pre-
sentation to hospital or within 48 h of hospital admission so as to
avoid observing hospital-acquired infections. All the stool speci-
mens were stored in a freezer at −20 ◦C until testing and sufﬁcient
care was taken to avoid freeze–thaw cycles.
2.5. Detection of rotavirus
All the collected stools samples were tested for rotavirus VP6
antigen using a commercial enzyme immunoassay kit (Premier
Rota clone Qualitative EIA, Meridian Bioscience Inc., Cincinnati,
USA) at the respective study centers, in duplicates and with appro-
priate controls. All the rotavirus VP6 antigen positive stool samples
were sent for genotyping from the study centers to the Central
Laboratory at Department of Gastrointestinal Sciences, Christian
Medical College, Vellore under required controlled conditions.
2.6. Strain surveillance and characterization
Genotyping of all rotavirus positive stool samples was  con-
ducted at the Central Laboratory in Vellore. Genotyping was
performed by using Reverse-Transcription Polymerase Chain Reac-
tion (RT-PCR). Rotaviruses were classiﬁed into G- and P-types based
on the variability in the genes encoding the two  outer capsid pro-
teins, VP7 and VP4, respectively. Viral RNA was extracted from
stool specimens and reverse transcribed using random primers to
cine 32S (2014) A13–A19 A15
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Table 1
Distribution of rotavirus positive diarrhea by age, gender and season.
Stool samples tested Rotavirus positive n (%)
Age (months)
0–5 345 65 (18.8)
6–11 620 173 (27.9)
12–23 629 206 (32.8)
24–59 457 97 (21.2)
Total 2051 541 (26.4)
Gender
Male 1296 344 (26.5)T. Saluja et al. / Vac
enerate complementary DNA (cDNA). The cDNA was  used as tem-
late for genotyping in hemi-nested multiplex PCRs for VP7 and
P4 genes using published oligonucletide primers and protocols.
he primers were designed to amplify common rotavirus G- and
-types as well as genotypes that are more common in India.
RNA extraction and reverse transcription RNA extraction was
arried out using the instruction in the Qiagen stool minikit. With
luted RNA, cDNA is generated by reverse transcription using 400 U
f Moloney murine leukemia virus reverse transcriptase (M-MLV)
everse transcriptase in the presence of random primers (hexam-
rs; Pd(N)6) at 37 ◦C for 1 h. In each extraction, a rotavirus positive
tool sample as positive control and DEPC treated water as negative
ontrol were included. The cDNA was used as a template for G- and
-typing PCRs. Five microlitres of cDNA was used in ampliﬁcation
eactions for the ﬁrst round VP7 and VP4 gene products in 50 l
eactions and 1 l of this ampliﬁed product serves as template for
he 2nd round multiplex PCR.
For VP7 genotyping, the ﬁrst round PCR primers VP7-F and VP7-
 ampliﬁed an 881 bp region of the VP7 gene. The nested multiplex
CR incorporated the reverse primer (VP7-R) and the primers spe-
iﬁc for ampliﬁcation of genotypes G1, G2, G3, G4, G8, G9, G10 and
12. Primers Con2 and Con3 were used in the ﬁrst round PCR to
mplify an 876 bp fragment of the VP4 gene. The second round
CR included the consensus primer Con3 and primers speciﬁc for
enotypes P[4], P[6], P[8], P[9], P[10] and P[11].
The genotypes were identiﬁed based on the PCR amplicon size
n gel electrophoresis. PCR amplicons were resolved in 2% agarose
els stained with ethidium bromide (0.5 mg/ml) in Tris–Boric
cid–EDTA (TBE) buffer at constant voltage. Images were photo-
raphed under UV light using a gel documentation system
.7. Statistical analysis
Diarrheal hospital log book, case report forms and genotype
esult reports were used to generate data for statistical analysis. All
ogs and forms were scrutinized for completeness, the data entered
nto Excel 2012 (Microsoft, Redmond, WA,  USA) and cleaned. Anal-
sis was performed using QuickCalcs, version 5 (GraphPad Software
nc., La Jolla, CA, USA). Tests of proportion, Chi-squared tests were
pplied and a P value <0.05 was considered to be statistically sig-
iﬁcant.
.8. Ethics
The study was conducted according to The Code of Ethics
f the World Medical Association (Declaration of Helsinki), GCP
uidelines issued by the Central Drug Standards and Control
rganisation, India and the ethical guidelines by Indian council
f Medical Research. Independent Ethics Committee/Institutional
eview Board clearance was obtained before initiation of the study
t each study center. The study was formally registered under
he Clinical Trials Registry – India with a registration number of
TRI/2012/03/002475.
. Results
.1. Gender and age
During the 16-month surveillance period from April 2011
hrough July 2012, a total of 4711 children aged <5 years were
dmitted to the various medical centers with diarrhea and a diag-
osis of acute gastro-enteritis as per the case deﬁnition. Out of
he 4711 cases, 702 (14.90%) were in the age group 0–5 months,
319 (27.99%) in the age group 6–11 months, 1559 (33.09%) in theFemale 755 197(26.1)
Total 2051 541 (26.4)
age group 12–23 months and 1131 (24%) in the age group 24–59
months.
Of the 4711 admissions, stool samples were collected from 2051
consenting (43.5%) subjects and analyzed for VP6 rotavirus antigen
in stool using the commercial enzyme immunoassay kit (Premier
Rota clone Qualitative EIA) at respective study sites. Out of the 2051
stool samples, overall 541 samples were positive for rotavirus VP6
antigen, representing 26.4% of subjects hospitalized due to acute
gastroenteritis. The rate of rotavirus positive stool samples ranged
from as high as 52.5% recorded in December 2011 to as low as
10.3% recorded in May  2011. The highest percentages of cases pos-
itive for rotavirus occurred in the age groups 12–23 months and
6–11 months at all sites (32.75% and 27.9%, respectively). Of all
children with rotavirus positive diarrhea, 18.84% were aged less
than 6 months. Children less than 2 years of age represented 82%
of the total disease burden. The mean age in months (± standard
deviation) of rotavirus infected hospitalized children (15.19 ± 4.08)
was lower when compared to the mean age of rotavirus uninfected
hospitalized children (17.00 ± 4.26) which is a statistical signiﬁcant
difference (P value < 0.01).
In addition to the reported 16 months data, data were analyzed
separately for 12 months from August 2011 to July 2012 for over-
all rotavirus positive diarrhea during one complete calendar year.
During this calendar year, out of 3917 severe diarrheal admission,
stool samples were collected from 1868 consenting (47.7%) subjects
and analyzed for VP6 rotavirus antigen in stool using the commer-
cial enzyme immunoassay kit (Premier Rota clone Qualitative EIA)
at respective study sites. Out of the 1868 stool samples, overall
516 samples were positive for rotavirus VP6 antigen, representing
27.62% of subjects hospitalized due to acute gastroenteritis.
Out of the 2051 cases who  provided stool samples for the study,
63.18% subjects were males. However rotavirus positivity showed
no signiﬁcant difference between male and female subjects (26.5%
among males and 26.1% among females) (Table 1).
The severity of disease was higher in rotavirus infected chil-
dren than the rotavirus uninfected children (Table 2). In spite of
the duration of the hospital stay being similar for both rotavirus
infected and rotavirus uninfected children, the infected children
presented slightly more vomiting episodes.
3.2. Geographical distribution
Rotavirus antigen positivity in stools varied from region to
region across India. The average rotavirus positivity reported from
various regions was  as follows: North India 20.9% (range across
study period 0.0–53.3%), Eastern India 24.6% (range across study
period 0.0–58.6%), South India 33.9% (range across study period
0.0–66.7%) and 29.9% (range across study period 0.0–53.1%) from
Western part of India. The difference reported from the four regions
is statistically signiﬁcant having two-tailed P value of 0.0342 using
the Chi-square test. No statistically signiﬁcant differences were
observed between regions by gender.
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Table 2
Characteristics of rotavirus-infected and uninfected children hospitalized with acute gastroenteritis.
Variables Rotavirus infected children (n = 541) Rotavirus uninfected children (n = 1510) P value
Gender
Male 344 (63.58%) 948 (62.78%) –
Female 197 (36.42%) 562 (37.22%) –
Age, mean months ± SD 15.19 ± 4.08 17.00 ± 4.26 <0.01
Hospital stay, mean days ± SD 3.14 ± 1.58 2.97 ± 1.44 0.02
Vomiting (for >3 days) 182 (33.64%) 492 (32.58%) –
Episodes  (for >5 days) 161 (29.75%) 557 (36.89%) –
Vesikari  score, mean ± SD 14.42 ± 1.90 13.64 ± 2.08 <0.01
Disease severity by
Vesikari score
Mild 6 (1.1%) 9 (0.59%) –
Moderate 49 (9.06%) 183 (12.12%) –
Severe 295 (54.53%) 748 (49.54%) –
Very severe 191 (35.30%) 570 (37.75%) –
Fig. 2. Seasonality of rotavirus positive diarrhea.
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.3. Seasonality
Of the 4711 cases of acute severe gastroenteritis recorded, all
tudy sites combined reported the highest number of cases in
he month of May  2012 and the lowest number of cases in the
onth of April 2011 (Fig. 3). Northern, southern, eastern and
estern parts of India reported highest numbers of cases in the
onths of June 2012, July 2012, May  2012 and June 2012 respec-
ively while they reported lowest number of cases in the monthsa and percentage rotavirus positivity.
of March 2012, August 2011, April 2011 and November 2011,
respectively.
A distinct seasonality of rotavirus positivity was observed in dif-
ferent parts of India with peak months of rotavirus hospitalization
from December through February in north, east and western parts
of India. In south India, rotavirus hospitalizations were observed
throughout the year without any distinct seasonal peak (Fig. 2).
Rotavirus related hospitalizations were highest from October
through March for all the regions (Table 3).
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Table  3
Regional distribution of rotavirus positive diarrhea by age, gender and season.
Age (months) North East South West
Stool samples tested RV +ve (%) Stool samples tested RV +ve (%) Stool samples tested RV +ve (%) Stool samples tested RV +ve (%)
0–5 164 27 (16.4) 59 9 (15.2) 22 9 (40.9) 100 20 (20.0)
6–11  225 52 (23.1) 163 39 (23.9) 57 18 (31.6) 175 64 (36.5)
12–23 175 48 (27.4) 184 57 (30.9) 127 50 (39.4) 143 51 (35.6)
24–59 124 17 (13.7) 72 13 (18.0) 147 43 (29.2) 114 24 (21.0)
Total  688 144 (20.9) 478 118 (24.6) 353 120 (33.9) 532 159 (29.9)
Gender North East South West
Stool samples tested RV +ve (%) Stool samples tested RV +ve (%) Stool samples tested RV +ve (%) Stool samples tested RV +ve (%)
Male 440 96 (21.8) 292 70 (23.9) 211 70 (33.2) 353 108 (30.6)
Female 248 48 (19.3) 186 48 (25.8) 142 50 (35.5) 179 51 (28.5)
Total  688 144 (20.9) 478 118 (24.7) 353 120 (34.1) 532 159 (29.9)
Admission month North East South West
Stool samples tested RV +ve (%) Stool samples tested RV +ve (%) Stool samples tested RV +ve (%) Stool samples tested RV +ve (%)
January–March 79 30 (37.9) 79 29 (36.7) 64 29 (45.3) 220 97 (44.1)
April–June 350 64 (18.3) 160 19 (11.9) 162 44 (27.2) 175 22 (12.6)
34 (20.9) 89 28 (31.5) 85 14 (16.5)
36 (46.8) 38 19 (50.0) 52 26 (50.0)
118 (24.7) 353 120 (33.9) 532 159 (29.9)
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October–December 88 28 (31.8) 77 
Total  688 144 (20.9) 478 
.4. Genotyping
Strain characterization by ELISA for all stool samples that tested
ositive for rotavirus VP6 antigen was carried out. Genotyping was
erformed at the Central Laboratory using reverse-transcription
olymerase chain reaction (RT-PCR). The most dominant genotype
as G1P8 (23.84%) followed by G2P4 (12.93%) and G9P4 (8.13%)
Fig. 4 and Table 4).
The age speciﬁc analysis of genotyping revealed differences
ith increasing age: rotavirus infections due to G12P6, which were
esponsible for 7% of cases across all age groups, contributed toward
1% of burden in children less than 6 months. This decreased
o 8% in the age group 6–11 months and around 2–3% in chil-
ren older than 12 months of age. Across all age groups, mixed
nfections were responsible for nearly 25% of the positive cases
Fig. 5).
. Discussion
This study used a standardized approach based on the generic
rotocol for hospital-based surveillance to estimate the burden of
otavirus gastroenteritis in children [4]. On an average rotavirus
ntigen was detected in 26.4% (ranging from as high as 52.5% to
s low as 10.3%) of all diarrhea-related hospital admissions among
hildren aged less than 5 years during 16 months study period.
able 4
otavirus strain characterization.
Genotype P[4] P[6] P[8] P[4] & P[6] 
G1 14 20 129 1 
G2  70 20 1 3 
G4  0 1 0 0 
G9  44 8 27 1 
G12  3 37 8 1 
G1  and G2 6 0 2 2 
G1  and G4 0 0 0 0 
G1  and G9 1 0 2 3 
G1  and G10 0 0 0 0 
G1  and G12 0 4 2 0 
G2  and G9 0 0 0 0 
G2  and G12 0 0 0 1 
G1,  G2 and G9 0 0 0 0 
G  not typed 36 10 10 0 Fig. 4. Distribution of rotavirus strains in stools of severe diarrheal cases (n = 541)Overall 80% of rotavirus positive cases occurred among children
less than 2 years old.
Taking into account one complete calendar year from August
2011 to July 2012, rotavirus antigen was  detected in 27.6% (ranging
P[4] & P[8] P[6] & P[8] P[4], P[6] & P[8] P not typed
14 13 5 9
2 1 0 0
0 0 0 0
13 2 1 0
1 0 1 0
1 2 1 0
0 0 0 0
3 0 0 0
0 0 0 0
0 0 1 0
0 0 0 0
0 0 0 0
2 0 0 0
0 0 0 2
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rom as high as 52.5% to as low as 15.3%) of all diarrhea related
ospital admission among children aged less than 5 years.
A review of studies performed in India during 1990–2005
stimated that rotavirus disease accounted for 20.8% of all diar-
hea related hospital admissions [5] whereas Kang et al. reported
otavirus positivity in India at 39% [6] which is higher than the
verage positivity reported in our study.
This study also documents the early incidence of rotavirus
isease in India. The percentage of children with dehydrating gas-
roenteritis who were less than six months of age was as high as
2%. The youngest case recorded was one month old at the time
f hospitalization. An earlier study from central India showed that
otavirus disease was more common during cooler months, with
easonal peaks matching the lowest temperatures [7]. In this study,
 distinct winter peak was seen in the months of December to
ebruary during the total 16 months of surveillance across 12 sites
n India, especially in northern India which has a distinct winter sea-
on from November to February. Interestingly, the sites in southern
ndia did not demonstrate this trend as the area experiences the
east annual variation in temperature of the four regions.
The worldwide emergence of the G12 strain in 2005 and
ts increasing incidence during the past two years parallels the
mergence and subsequent spread of G9 strains that occurred
pproximately a decade ago. In the mid-1990s, G9P[6] and G9P[8]
trains were reported in India, Japan, the United Kingdom, and the
nited States. Subsequently, G9P[8] spread globally, and it cur-
ently accounts for 4.1% of all rotavirus infections [8]. In our study,
 higher percentage of G12 (17.74%) was observed especially in the
astern part of India as compared to the rest of India. Various stud-
es have found G12 strains in association with multiple VP4 types,sitive stool from severe diarrheal cases.
namely P[4], P[6], P[8], and P[9], suggesting re-assortment among
commonly circulating strains [9,10].
The increased reporting of infection with G12 strains may  be
associated with re-assortment, resulting in generation of a strain
that is better adapted to replication in humans, similar to the events
that preceded the spread of G9 strains in the past decade. The emer-
gence of G12 strains highlights the need for a surveillance system
to respond rapidly to changes in circulating virus and to ensure that
vaccines remain effective against emerging strains.
Reported G12 cases from our study provided further evidence
of the notion that G12 strains should no longer be considered as
unusual or rare strains but that they exhibit a capacity to spread
among children just like human rotavirus strains of other com-
monly seen G types.
In addition to the challenges posed by the emergence of new
strains in the population under surveillance, we found high lev-
els of circulation of unusual recombinant strains, such as G1P[4],
G1P[6], G2P[6], G2P[8], G9P[4], and G9P[6] in different parts of
the country. This indicates that there may  be both regional and
temporal variations in rotavirus strain predominance, which will
be important to consider when assessing the impact of vaccina-
tion on rotavirus strains. Continued rotavirus strain surveillance
after vaccine introduction will allow for epidemiologic assessment
of vaccine effectiveness against the range of currently circulating
strains and other potential strains that may  be identiﬁed in the
future. Both the number of re-assortant strains and the high pro-
portion of mixed infections are indications of the variety of sources
from which children are likely to acquire infections. Of rotavirus-
positive specimens, some remained untypeable for both G type and
P types. Possible explanations include too few virus particles with
cine 32
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ntact RNA in the stool specimens, the viruses not being recognized
y the primer sets, and the viruses not belonging to genotypes
ncluded in the primer set.
Since the study protocol was set up to capture acute gastroen-
eritis cases reporting to only one clinic in each of the study sites and
here was no active effort to look for and log every case of diarrhea
eporting to the hospital and attached health centers, there is a pos-
ibility that the estimation of the number of acute diarrhea cases
n the study age group is lower than the actual number of cases.
dditionally, this manuscript may  have possibility of potential bias
ue to under reporting of severe rotavirus-positive diarrhea due
o inclusion of two low rotavirus-positive seasons (April 2011–July
011 and April 2012–July 2012) and only one high rotavirus posi-
ive season (August 2011–March 2012).
In summary, this study highlights the high prevalence of
otavirus gastroenteritis in India, the higher severity of rotavirus
isease than that of other diarrheal diseases, and the circulation of
 diverse range of rotavirus strains, including several uncommon
nd emerging strains like G9 & G12. This study report has generated
eographically representative data to inform public health policy
n India. With the prospect of rotavirus vaccine introduction in the
ndian EPI Schedule in the near future, the importance of rigorous
urveillance to monitor disease and strains before and after vaccine
ntroduction cannot be overemphasized.
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